How is Carfilzomib synthesized?

The synthesis of Carfilzomib (Carfilzomib) is a complex and multi-step process, which relies on organic chemical synthesis methods. The following is the general synthesis process of carfilzomib:

1.Starting materials: The starting materials for the synthesis of carfilzomib are usually commercially available compounds. In this process, an intermediate compound called Carfilzomib (Carfilzomib) is used as a starting material.

2.Reaction1 - Preparation of Kafepp: The preparation of Kafepp is the first step in the synthesis process. This is done by reacting the appropriate chemicals with intermediates to form kafep.

3.Reaction2 - Preparation of the final product: Carfilpro is the core of the synthesis of carfilzomib. It then undergoes a complex series of reactions, including chemical reactions and separation steps, to gradually transform into carfilzomib. These reactions may involve addition of specific functional groups, cyclization, removal of protecting groups, etc.

4.Purification: Every step in the synthesis process requires purification to ensure the purity of the product. This includes using techniques such as chromatography, crystallization, and filtration to isolate and purify the target product.

5.Quality control: At each stage of synthesis, quality control steps will be performed to ensure that the quality, purity and structure of the final synthesis product meet standards. This is to ensure the therapeutic efficacy and safety of carfilzomib.

6.Final product: Once the synthesis of carfilzomib is complete and passes quality control, it will be formulated into a pharmaceutical form suitable for use, usually as a lyophilized powder or solution. This allows it to be supplied as a drug to medical institutions and doctors for the treatment of multiple myeloma patients.

It needs to be emphasized that the preparation process of synthetic drugs such as carfilzomib requires a high degree of professional skills and equipment. In addition, each batch of synthetic drugs must undergo rigorous quality control and testing to ensure that it meets the standards of drug regulatory agencies to provide a safe and effective treatment option.

Carfilzomib has been launched in China and is included in medical insurance. Patients can purchase it domestically at a price of around 8,000 to 9,000 yuan. Please consult the local hospital pharmacy for specific prices. In foreign countries, the original drug of carfilzomib is mainly available, and the cheaper version is the European version of the original drug, which costs around 5,000. And the medicinal ingredients and efficacy are the same as those of domestic original medicines.